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Summary
Introduction: The asthma mortality pattern differs among countries. No published
evidence is currently available on asthma mortality in a European low-middle-income
country in socioeconomic transition. We analyzed the trend of asthma mortality rate in
Serbia during the period 1980–2009.
Materials and Methodology: a descriptive study; source of data: Republic of Serbia
Institute of Statistics Death Registry. We analyzed asthma mortality data in the total
population, including gender speciﬁc analysis, and in the selected 5–34 year age group.
The International Classiﬁcation of Diseases codes for asthma 493 (1980–1996) and J45+J46
(1997–2009) were included. Population estimates were based on 1991 and 2002 census
data, with extrapolation.
Results: The over-all average mortality rate was 7.27±2.14/100,000 inhabitants. The
mortality rate peaked in 1981 at 11.3/100,000 but was 4.45/100,000 in the last year
of analysis. While both overall mortality rate, as well as gender speciﬁc rates, showed
clear decreases over the observed 30-year period (average absolute annual decrease of
0.195/100,000 inhabitants, 0.241/100,000 men and 0.149/100,000 women; p < 0.001) with
corresponding relative annual decreases of 2.9% for the whole population, 3.0% for men
and 2.8% for women, a stable trend of the rate was found in the age group 5–34 years.
Male-to-female ratio was 1.59±0.186, on average and it showed a stable trend over the
observed period.
Conclusion: Although the failure of the health care system during the socioeconomic crisis
of the 1990s might have transiently affected asthma mortality rates, the overall mortality
rate for the disease shows a favorable decreasing trend.
© 2011 Elsevier Ltd. All rights reserved.
Introduction
Asthma is a major public health problem. The project Global
Burden of Asthma showed variable burdens and trends of
the disease worldwide.1–3 The reasons for exacerbations of
severe asthma are complex and include underestimation by
* Corresponding author. Prof. Dragica Pesut, MD, PhD.
Teaching Hospital of Lung Diseases, Clinical Centre of Serbia,
11000 Belgrade, Visegradska 26, Serbia.
Tel.: 381 11 366 39 56; fax: 381 11 268 15 91.
E-mail: dragica.pesut@gmail.com (D. Pesut).
the patients or failure of health care. If not recognized
and treated properly, these exacerbations can be fatal.4,5
Although asthma related deaths are rare and should be
entirely avoidable, the mortality from this disease has even
shown an increased tendency in the last few decades.3
Speciﬁc factors that have been identiﬁed as associated
with a higher risk of asthma mortality include a previous
history of life threatening acute attacks, hospitalization
within the previous year, psychosocial problems, a history
of intubations for asthma, recent reductions or cessation of
glucocorticosteroid therapy and non compliance with rec-
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ommended therapy.4,6 Although with conﬂicting evidence,
some drugs like long-acting b-agonists may also contribute
to asthma related death.7 Individuals at risk of death from
asthma are more likely to be non-Caucasian and young8 but
African American patients are not at increased risk for death
relative to Caucasian/Semitic ones.9 Some recent results
support the existence of a genetic basis to the severe asthma
phenotype, including asthma-related death.10
Several unfavorable trends and epidemics of fatal asthma
have been registered in various developed countries of
Europe, the United States of America and New Zealand
over the last three decades.11 International comparisons
revealed some striking differences in the pattern of asthma
mortality.8,12 Country-speciﬁc data on asthma mortality
rates since 1960 in the 5- to 34-year-old age group were
collated recently. Elevated asthma mortality rates were
observed in the 1960s, with a mean increase of 53% from
0.55 per 100,000 in 1960 and 1961 to a peak of 0.84 in 1966
and 1967.11 This trend was followed by a progressive decline
to a nadir of 0.45 per 100,000 in 1974 and 1975. Asthma
mortality rates then gradually increased again to a peak of
0.62 per 100,000 in 1985 and 1986, with a mean increase of
38%.3,8 Since the late 1980s, there has been a widespread
and progressive overall 63% reduction in mortality rate down
to 0.23 per 100,000 in 2004 and 2005.3,11
We analyzed asthma mortality in Serbia between 1980
and 2009. The socioeconomic crisis in this South Eastern
European country in the 1990s heavily affected the health
care system and led to serious interruption of medical
supplies, which could affect asthma mortality rates.13
Materials and methodology
We provided the data for this 30-year descriptive study
from the Death Registry of the Republic of Serbia Institute
of Statistics in Belgrade. The International Classiﬁcation of
Diseases (ICD) codes for asthma 493 (1980–1996) and J45+J46
(1997–2009) were included in the analysis. The existing ICD
was replaced by ICD 10 in January 1997. While the earlier
ICD included 493 as the only code for asthma, the new
classiﬁcation used both J 45 and J 46 to distinguish between
more and less severe forms of asthma.
Apart from the asthma mortality rates for the whole
population of Serbia (7,320,807 inhabitants in 2009), we
separately analyzed the 5–34 age group because the
diagnosis of asthma mortality is ﬁrmly established for
this latter one. Namely, it has been shown that in
the 5–34 years age group false-positive reporting (i.e.
deaths from other causes falsely attributed to asthma) and
false-negative reporting (i.e. asthma-related deaths falsely
assigned to other categories) were extremely low.1 However,
the accuracy of this approach declines with increasing age,
with false positive reporting rates of >30% in those aged
65 years or more.1
Population estimates based on 1991 and 2002 census
data with extrapolation were used to calculate asthma
mortality rates in the observed period. A regression line was
ﬁtted to the annual age speciﬁc mortality rates for (a) all
ages, for (b) the 5–34 age group and (c) gender speciﬁc
mortality to ascertain the probability (p) values. Mortality
rates were expressed as number of asthma related deaths
per 100,000 (No/100,000) inhabitants. Gender speciﬁc rates
were calculated as numbers of male or female asthma-
related deaths per 100,000 male or female inhabitants,
respectively. Linear, log-lin regression models and the
least squares method were used to test trends and ﬁt
trend lines. For linear regression: value on the vertical
axis = intercept +/– slope multiplied by the value on the
horizontal axis + stochastic error term (Yt =a0 +a1t + et).
The slope a1 represents the average absolute annual
change of Y when the annual trend is tested. The log-
lin model (lnYt = b0 + b1t + et, where lnYt denotes natural
logarithm of Yt) was used in order to estimate and test
the average relative annual change of Y, expressed as
(b1–1)100%. The IBM SPSS (Statistical Package for the Social
Sciences) Statistics, version 19 was used to estimate and
test regression coefﬁcients.
Results
The over-all average asthma mortality rate was 7.27±2.14/
100,000 inhabitants (95% conﬁdence interval [CI], 6.48–
8.07). The rate peaked in 1981 with 11.3/100,000 and
decreased to 4.45/100,000 in the last year of analysis. The
average gender speciﬁc mortality rates were signiﬁcantly
different (3.32±1.27, p < 0.001). Thus, total mortality
rate showed a clear decline over the observed 30-year
period (absolute average annual decrease: 0.195; p < 0.001;
95%CI, –0.251; –0.139) with a relative annual decrease
of 2.9% (Fig. 1). Gender related rates showed similar
Fig. 1. Trend of asthma mortality rate in Serbia in the period
1980–2009. Total mortality rate decreased over the observed
30-year period (y = 10.07 – 0.179x; p < 0.001) while a slight non-
signiﬁcant increase of asthma mortality rate was seen in the age
group 5–34 years (y = 0.203+0.001x; p = 0.744). Mortality rate is
expressed as case numbers per 100,000 inhabitants (No/100,000).
Closed-rhombus line: asthma mortality rate in the total population
(full line is the trend line); open-rhombus line: asthma mortality
rate for ages 5–34 years.
decreasing trends in both sexes but more expressed in men
(–0.241/100,000 males or 3% annually; p < 0.001) than in
women (–0.149/100,000 females or 2.8% annually; p < 0.001)
(Fig. 2). Asthma mortality rate in the age group 5–34 years
was 0.21±0.09/100,000 inhabitants, with a relatively stable
trend during the analyzed period (Fig. 1). The male-
to-female ratio showed that male asthma-related deaths
predominated over female ones for all the years of the
analysis (mean: 1.59±0.186). The ratio trend was stable
over the period, being the lowest in the last two years
(Fig. 3).
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Fig. 2. Time trend of gender speciﬁc asthma mortality rates in
Serbia, 1980–2009, No/100,000 inhabitants. Gender related rates
showed similar decreasing trends in both sexes. This was more
expressed in males (–0.241/100,000 men or 3%, annually; p < 0.001)
than in females (–0.149/100,000 women or 2.8%, annually;
p < 0.001).
Fig. 3. Male-to-female ratio in asthma-related mortality in Serbia,
1980–2009. The male-to-female ratio (thick line) shows that male
cases predominated over female ones for all the years of the
analysis (mean value 1.59±0.186). The time trend is stable.
Discussion
The overall asthma related mortality in our study showed a
decreasing trend over the period 1980–2009. In Scandinavian
countries, asthma mortality rates have declined markedly
over the last ten years,1 a trend attributed to improvements
in asthma management, and similar ﬁndings were recently
reported in France.14 Although the reduction in mortality
rates generally was consistent among several countries,
there was variation in the timing of its onset.11 While
our mortality rates peaked in 1981, this happened in
England and Wales in 1987, with a progressive decline up
to 2005, whereas in the United States, mortality did not
peak until 1995, with a subsequent decline to 2005.11 The
decrease in our study was especially evident during the
last few years, which were characterized with steadily
improved treatment, as new generations of drugs1 were both
available and accessible for the majority of patients. The
national adherence to globally accepted modern approaches
in the diagnostics and management of asthma resulted in
easy-to-access guidelines to facilitate health care workers’
practice and education. General awareness about asthma
symptoms, education of patients and implementation of
self-management programs in asthma treatment15 could also
improve early detection of instability and worsening of
the disease, prevent an unfavorable disease outcome and
contribute to over-all reduction of asthma mortality.
Our study also showed a rather stable trend of asthma
mortality rate of 0.21±0.09/100,000 on average in the
selected 5–34 year age group. Among the twenty countries
recently included in an analysis of asthma mortality rate
per l00,000 inhabitants in the same age group, the lowest
average rate of 0.14 was found in Finland, and the highest
of 1.4 in New Zealand.11 The average asthma mortality rate
in this age group in our study is similar to values observed in
Spain and the Netherlands during the same 30-year period11
but lower than those found in Norway (0.26), Australia (0.3),
Sweden (0.3), France (0.35), Canada (0.41), United States
(0.42) and Germany (0.49). In Japan, the Republic of Ireland,
England, Hong Kong and Austria, rates were higher than
0.5/100,000 inhabitants. The stable trend in this age group
found here compared to the decreasing trend of overall
mortality rate, could be explained by the younger age8,16
and possible inﬂuence of exposure to outdoor and indoor
pollution, especially to environmental tobacco smoking,16–19
which is a serious problem in the local setting.20,21 There is
overwhelming evidence that exposure to parental smoking
has obvious adverse effects upon the respiratory health of
young children.18,19 Gergen et al. found an increased odds
ratio of 2–3 for asthma in children 2 months to 5 years
old16 and some studies also included maternal smoking
during pregnancy to show that the effects of exposure to
tobacco smoke started before birth.22 Anti-tobacco policies
and strengthening programs for prevention and cessation of
tobacco smoking might have a considerable positive effect
on disease severity and lethal outcome in a number of
patients, especially in the younger age group.22
Although a distinctive feature of asthma mortality is the
low difference between the sexes,3 the results of our study
show the Male/Female ratio 1.59±0.186. In a Japanese
study based on the same methodology, asthma mortality
rates were higher in men than in women during the entire
study period between 1950 and 1997.23
The validation studies have shown signiﬁcant inaccuracies
in certiﬁcation of cause of death in older subjects,
and probable underreporting of asthma deaths in some
countries.8 These could explain some of the international
differences noted and may be a limitation of our study
as well. Our source of data was the National Institute
of Statistics with a tradition of recording and reporting
mortality from asthma and other diseases since 1947.
Validity of data collected by National Institute of Statistics
are further strengthened by the fact that Serbian data
are close to regional lowest asthma prevalence in the
Balkans with mean prevalence of clinical asthma 6.1% and
prevalence in Albania 1.1%, Romania 1.5%, and Greece
1.9%.1,4,24 Asthma mortality rates are generally low in
countries within this region, reﬂecting to some degree the
low prevalence rates.4
One pattern seen in most regions of the world is an
increase in asthma mortality rate with increasing age.1
Even taking into consideration the decline in certiﬁcation
accuracy in older age groups, this does indicate a
considerably greater risk of death in older asthmatics and
the importance of care in this group.1 Introduction of the
ninth revision of the World Health Organization International
Classiﬁcation of Diseases brought a steep increase in
reported asthma mortality rates in 1979.1 Detailed analysis
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of our mortality rate line revealed that the rate dropped
only after the ﬁrst few years of analysis (Fig. 1). However,
the gradual increase in mortality rates in many countries
during the 1980s and 1990s could not be explained by this
change in code.8 After 1984, asthma mortality rates in Serbia
showed rather stable rates below 8.3/100,000 except for
1998 when health care services failed and there was a
serious shortage of medical supplies.13
It is still estimated that asthma accounts for about
one in every 250 deaths worldwide.1 Many of them are
preventable, being due to suboptimal long term medical
care and delay in obtaining help during the ﬁnal attack.1
This may also depend on the particular socioeconomic
conditions, which inﬂuence access to health care and are
different among countries.1 Currently, new directions for
novel asthma therapies have been proposed, which may
inﬂuence asthma mortality in the future.25
Conclusion
Although failure of the health care system during the
socioeconomic crisis of the 1990s might have transiently
affected asthma mortality rates in Serbia, the over-
all asthma-related mortality rate showed a favorable
decreasing trend during the examined 30-year period.
Nevertheless, asthma-related death remains a challenge,
especially for treatment related investigations that could
point to more effective therapy, leading to further mortality
decrease and possibly primary prevention of the disease.
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